FDA 483 OBSERVATION · #11 OF 1,923 MOST-CITED
Equipment and utensils - Design and maintenance
FDA cited this observation 1,127 times across 1,026 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
Equipment and utensils were not designed, constructed, or maintained appropriately for their use — surfaces were not cleanable, equipment was in disrepair, or maintenance and cleaning were inadequate to prevent contamination or cross-contamination.
Why FDA writes it — Equipment is the physical interface with the product. Poorly designed or maintained equipment cannot be reliably cleaned, harbors residue and contaminants, and is a recurring source of adulteration — so FDA treats design and upkeep as a direct product-safety control.
- Use equipment and utensils of appropriate design, material, and workmanship for their intended use, with food- or product-contact surfaces that are cleanable and resist corrosion and residue.
- Establish and follow written cleaning and maintenance schedules, and keep records demonstrating they are performed.
- Maintain equipment in a state of repair that prevents contamination — address leaks, worn seals, flaking surfaces, and lubricant migration.
- Qualify and control equipment where the process demands it, and verify cleaning effectiveness for shared or product-contact equipment.
- Equipment kept in service past the point where its surfaces can be effectively cleaned, prioritizing uptime over cleanability.
- Cleaning and maintenance performed reactively without a documented schedule, so lapses are invisible until an inspection.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 0.9× the rate of the average FDA-cited firm (6.7% vs 7.8%), across 1,026 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
Your equipment and utensils were not designed and constructed to be adequately cleaned or maintained to protect against contamination.
Your equipment and utensils were not designed and constructed to be adequately cleaned or maintained to protect against contamination.
Your equipment and utensils were not designed and constructed to be adequately cleaned or maintained to protect against contamination.
Your equipment and utensils were not designed and constructed to be adequately cleaned or maintained to protect against contamination.
Your equipment and utensils were not designed and constructed to be adequately cleaned or maintained to protect against contamination.
Your equipment and utensils were not designed and constructed to be adequately cleaned or maintained to protect against contamination.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →